SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-017913
Filing Date
2018-10-03
Accepted
2018-10-03 16:41:02
Documents
5
Period of Report
2018-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20181003_8k.htm 8-K 28361
2 EXHIBIT 10.1 ex_125034.htm EX-10.1 34579
3 EXHIBIT 10.2 ex_125035.htm EX-10.2 6616
4 EXHIBIT 10.3 ex_125036.htm EX-10.3 6648
5 EXHIBIT 10.4 ex_125037.htm EX-10.4 6458
  Complete submission text file 0001437749-18-017913.txt   84345
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26422 | Film No.: 181105537
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1